InsiderPulse| Date | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sale | 9,000 | $33.40 | $301K | 81.4K | View ↗ | |
| 2026-04-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sale | 9,000 | $35.51 | $320K | 85.4K | View ↗ | |
| 2026-03-02 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sale | 9,000 | $29.72 | $267K | 89.4K | View ↗ | |
| 2026-02-02 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sale | 9,000 | $33.93 | $305K | 57.7K | View ↗ | |
| 2026-01-08 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sale | 5,000 | $30.00 | $150K | 61.7K | View ↗ |
No annual data found.
Pacira Q1 Earnings Miss Estimates on Higher Costs, Revenues Rise Y/Y
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Earnings Preview: Alkermes (ALKS) Q1 Earnings Expected to Decline
Wall Street Analysts Believe Alkermes (ALKS) Could Rally 29.14%: Here's is How to Trade